Celldex Therapeutics (CLDX) PT Lowered to $38 at Wells Fargo
Tweet Send to a Friend
Wells Fargo analyst Derek Archila lowered the price target on Celldex Therapeutics (NASDAQ: CLDX) to $38.00 (from $44.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
